UTHR UNITED THERAPEUTICS CORP DEL
FollowStock (common), issuer CIK 1082554
653 managers (673 13F filers) reported a position in UTHR shares at 2025-06-30, 43,971,331 shares in all. 68 filers opened a position and 71 filers sold out during the quarter.
- Managers
- 653
- 13F filers
- 673
- New
- 68
- Added
- 283
- Reduced
- 221
- Sold out
- 71
- Shares held by filers
- 43,971,331
Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.
13D and 13G filers
No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.
Insider trades
| Owner | Date | Shares | Price | Filing |
|---|---|---|---|---|
| ROTHBLATT MARTINE Adirector, officer (Chairperson & CEO) | 2026-10-13 | -80 S | $551.49 | Form 4 |
| ROTHBLATT MARTINE Adirector, officer (Chairperson & CEO) | 2026-10-13 | -160 S | $550.5929 | Form 4 |
| ROTHBLATT MARTINE Adirector, officer (Chairperson & CEO) | 2026-10-13 | -502 S | $549.4687 | Form 4 |
| ROTHBLATT MARTINE Adirector, officer (Chairperson & CEO) | 2026-10-13 | -698 S | $548.4875 | Form 4 |
| ROTHBLATT MARTINE Adirector, officer (Chairperson & CEO) | 2026-10-13 | -630 S | $547.4724 | Form 4 |
| ROTHBLATT MARTINE Adirector, officer (Chairperson & CEO) | 2026-10-13 | -1,452 S | $546.4596 | Form 4 |
| ROTHBLATT MARTINE Adirector, officer (Chairperson & CEO) | 2026-10-13 | -1,507 S | $545.5221 | Form 4 |
| ROTHBLATT MARTINE Adirector, officer (Chairperson & CEO) | 2026-10-13 | -1,492 S | $544.5594 | Form 4 |
| ROTHBLATT MARTINE Adirector, officer (Chairperson & CEO) | 2026-10-13 | -2,340 S | $543.4827 | Form 4 |
| ROTHBLATT MARTINE Adirector, officer (Chairperson & CEO) | 2026-10-13 | -639 S | $542.7569 | Form 4 |
| ROTHBLATT MARTINE Adirector, officer (Chairperson & CEO) | 2026-10-13 | +9,500 M | $117.76 | Form 4 |
| ROTHBLATT MARTINE Adirector, officer (Chairperson & CEO) | 2026-10-12 | -135 S | $554.4568 | Form 4 |
| ROTHBLATT MARTINE Adirector, officer (Chairperson & CEO) | 2026-10-12 | -558 S | $552.9294 | Form 4 |
| ROTHBLATT MARTINE Adirector, officer (Chairperson & CEO) | 2026-10-12 | -1,857 S | $551.9223 | Form 4 |
| ROTHBLATT MARTINE Adirector, officer (Chairperson & CEO) | 2026-10-12 | -2,628 S | $551.1025 | Form 4 |
13F holders, Q2 2025
Filers in the available 13F reports with a share position at 2025-06-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
Events
ROTHBLATT MARTINE A reported transactions in UTHR shares with no net change in a Form 4 filed 2026-10-14. 0001106578-26-000163
Accepted , ingestedROTHBLATT MARTINE A reported transactions in UTHR shares with no net change in a Form 4 filed 2026-10-13. 0001106578-26-000162
Accepted , ingestedROTHBLATT MARTINE A reported transactions in UTHR shares with no net change in a Form 4 filed 2026-10-13. 0001106578-26-000161
Accepted , ingestedROTHBLATT MARTINE A reported transactions in UTHR shares with no net change in a Form 4 filed 2026-10-09. 0001106578-26-000160
Accepted , ingestedROTHBLATT MARTINE A reported transactions in UTHR shares with no net change in a Form 4 filed 2026-10-08. 0001106578-26-000159
Accepted , ingestedROTHBLATT MARTINE A reported transactions in UTHR shares with no net change in a Form 4 filed 2026-10-07. 0001106578-26-000158
Accepted , ingestedROTHBLATT MARTINE A reported transactions in UTHR shares with no net change in a Form 4 filed 2026-10-06. 0001106578-26-000157
Accepted , ingested